Ono Pharmaceutical Co., Ltd.
4528.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥800,159,659 | ¥732,372,989 | ¥746,063,105 | ¥768,205,193 |
| - Cash | ¥182,060,000 | ¥138,991,000 | ¥204,567,000 | ¥160,982,000 |
| + Debt | ¥130,415,000 | ¥138,111,000 | ¥146,678,000 | ¥154,286,000 |
| Enterprise Value | ¥748,514,659 | ¥731,492,989 | ¥688,174,105 | ¥761,509,193 |
| Revenue | ¥129,600,000 | ¥127,536,000 | ¥112,309,000 | ¥134,223,000 |
| % Growth | 1.6% | 13.6% | -16.3% | – |
| Gross Profit | ¥94,637,000 | ¥90,523,000 | ¥67,072,000 | ¥88,387,000 |
| % Margin | 73% | 71% | 59.7% | 65.9% |
| EBITDA | ¥40,064,000 | ¥32,661,000 | -¥5,788,000 | ¥24,045,000 |
| % Margin | 30.9% | 25.6% | -5.2% | 17.9% |
| Net Income | ¥22,499,000 | ¥17,589,000 | -¥6,545,000 | ¥14,951,000 |
| % Margin | 17.4% | 13.8% | -5.8% | 11.1% |
| EPS Diluted | 47.89 | 37.58 | -13.93 | 31.81 |
| % Growth | 27.4% | 369.8% | -143.8% | – |
| Operating Cash Flow | ¥51,191,000 | ¥3,373,000 | ¥38,996,000 | ¥8,740,000 |
| Capital Expenditures | -¥1,660,000 | -¥2,250,000 | -¥1,421,000 | -¥1,204,000 |
| Free Cash Flow | ¥49,531,000 | ¥1,123,000 | ¥37,575,000 | ¥7,536,000 |